Literature DB >> 30198023

The interferon response as a common final pathway for many preconditioning stimuli: unexpected crosstalk between hypoxic adaptation and antiviral defense.

Saravanan S Karuppagounder1,2, Yujia Zhai1,2,3, Yingxin Chen1,2, Rongrong He3, Rajiv R Ratan1,2.   

Abstract

Despite major advances in understanding how the brain goes awry in disease, identification of therapeutics for neuroprotection in stroke remains an unsolved challenge. A promising strategy to delineate endogenous mechanisms of neuroprotection is to understand adaptive homeostatic transcription induced by sublethal ischemia. Homeostatic adaptation is defined as the body's restorative responses to stress. Activating adaptive homeostatic pathways can lead to transcription of a panoply of genes involved in cell survival and repair, can suppress pro-death signaling, and can stimulate metabolic changes congruent with survival. All of these mechanisms have been shown to be operative in protection induced by sublethal stress. In this context, central mediators of cellular adaptation to hypoxic and viral stress have been implicated in preconditioning. Here we present data that suggest an unexpected convergence in the pathways triggering adaptation to hypoxia and viral infection leading to preconditioning neuroprotection in the CNS.

Entities:  

Year:  2018        PMID: 30198023      PMCID: PMC6126377     

Source DB:  PubMed          Journal:  Cond Med        ISSN: 2577-3240


  61 in total

1.  Induced tolerance to ischemia in gerbil hippocampal neurons.

Authors:  T Kirino; Y Tsujita; A Tamura
Journal:  J Cereb Blood Flow Metab       Date:  1991-03       Impact factor: 6.200

2.  Antihelminthic benzimidazoles are novel HIF activators that prevent oxidative neuronal death via binding to tubulin.

Authors:  Hossein Aleyasin; Saravanan S Karuppagounder; Amit Kumar; Sama Sleiman; Manuela Basso; Thong Ma; Ambreena Siddiq; Shankar J Chinta; Camille Brochier; Brett Langley; Renee Haskew-Layton; Susan L Bane; Gregory J Riggins; Irina Gazaryan; Anatoly A Starkov; Julie K Andersen; Rajiv R Ratan
Journal:  Antioxid Redox Signal       Date:  2015-01-10       Impact factor: 8.401

3.  Remote ischemic limb preconditioning after subarachnoid hemorrhage: a phase Ib study of safety and feasibility.

Authors:  Sebastian Koch; Michael Katsnelson; Chuanhui Dong; Miguel Perez-Pinzon
Journal:  Stroke       Date:  2011-03-17       Impact factor: 7.914

4.  Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain.

Authors:  M Bergeron; J M Gidday; A Y Yu; G L Semenza; D M Ferriero; F R Sharp
Journal:  Ann Neurol       Date:  2000-09       Impact factor: 10.422

5.  Activation of the STING-Dependent Type I Interferon Response Reduces Microglial Reactivity and Neuroinflammation.

Authors:  Vidhu Mathur; Ritwik Burai; Ryan T Vest; Liana N Bonanno; Benoit Lehallier; Macy E Zardeneta; Karishma N Mistry; Danny Do; Samuel E Marsh; Edsel M Abud; Mathew Blurton-Jones; Lingyin Li; Hilal A Lashuel; Tony Wyss-Coray
Journal:  Neuron       Date:  2017-12-20       Impact factor: 17.173

6.  Hypoxia-inducible factor prolyl 4-hydroxylase inhibition. A target for neuroprotection in the central nervous system.

Authors:  Ambreena Siddiq; Issam A Ayoub; Juan C Chavez; Leila Aminova; Sapan Shah; Joseph C LaManna; Stephanie M Patton; James R Connor; Robert A Cherny; Irene Volitakis; Ashley I Bush; Ingrid Langsetmo; Todd Seeley; Volkmar Gunzler; Rajiv R Ratan
Journal:  J Biol Chem       Date:  2005-10-13       Impact factor: 5.157

7.  Adaptation of adult brain tissue to anoxia and hypoxia in vitro.

Authors:  A Schurr; K H Reid; M T Tseng; C West; B M Rigor
Journal:  Brain Res       Date:  1986-05-28       Impact factor: 3.252

8.  Neuronal deficiency of HIF prolyl 4-hydroxylase 2 in mice improves ischemic stroke recovery in an HIF dependent manner.

Authors:  Lexiao Li; Pamela Saliba; Stefan Reischl; Hugo H Marti; Reiner Kunze
Journal:  Neurobiol Dis       Date:  2016-03-19       Impact factor: 5.996

9.  Therapeutic targeting of oxygen-sensing prolyl hydroxylases abrogates ATF4-dependent neuronal death and improves outcomes after brain hemorrhage in several rodent models.

Authors:  Saravanan S Karuppagounder; Ishraq Alim; Soah J Khim; Megan W Bourassa; Sama F Sleiman; Roseleen John; Cyrille C Thinnes; Tzu-Lan Yeh; Marina Demetriades; Sandra Neitemeier; Dana Cruz; Irina Gazaryan; David W Killilea; Lewis Morgenstern; Guohua Xi; Richard F Keep; Timothy Schallert; Ryan V Tappero; Jian Zhong; Sunghee Cho; Frederick R Maxfield; Theodore R Holman; Carsten Culmsee; Guo-Hua Fong; Yijing Su; Guo-li Ming; Hongjun Song; John W Cave; Christopher J Schofield; Frederick Colbourne; Giovanni Coppola; Rajiv R Ratan
Journal:  Sci Transl Med       Date:  2016-03-02       Impact factor: 17.956

Review 10.  Harnessing hypoxic adaptation to prevent, treat, and repair stroke.

Authors:  Rajiv R Ratan; Ambreena Siddiq; Natalya Smirnova; Ksenia Karpisheva; Renee Haskew-Layton; Stephen McConoughey; Brett Langley; Alvaro Estevez; Patricio T Huerta; Bruce Volpe; Sashwati Roy; Chandan K Sen; Irina Gazaryan; Sunghee Cho; Matthew Fink; Joseph LaManna
Journal:  J Mol Med (Berl)       Date:  2007-11-28       Impact factor: 4.599

View more
  4 in total

1.  Tilorone and Cridanimod Protect Mice and Show Antiviral Activity in Rats despite Absence of the Interferon-Inducing Effect in Rats.

Authors:  Viktoriya Keyer; Laura Syzdykova; Gulzat Zauatbayeva; Aigerim Zhulikeyeva; Yerlan Ramanculov; Alexandr V Shustov; Zarina Shulgau
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-17

2.  A STING agonist preconditions against ischaemic stroke via an adaptive antiviral Type 1 interferon response.

Authors:  Nandini Kundu; Amit Kumar; Carlo Corona; Yingxin Chen; Sonia Seth; Saravanan S Karuppagounder; Rajiv R Ratan
Journal:  Brain Commun       Date:  2022-05-24

Review 3.  Neutrophils and Close Relatives in the Hypoxic Environment of the Tuberculous Granuloma: New Avenues for Host-Directed Therapies?

Authors:  Aude Remot; Emilie Doz; Nathalie Winter
Journal:  Front Immunol       Date:  2019-03-12       Impact factor: 7.561

Review 4.  COVID-19: Oxidative Preconditioning as a Potential Therapeutic Approach.

Authors:  Rachid Akki; Nada Fath; Hicham Mohti
Journal:  ACS Chem Neurosci       Date:  2020-11-05       Impact factor: 4.418

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.